IP Library Granted Patent US 9,103,965
Granted Patent B2
US 9,103,965 · App. 14/105,275 · Granted Aug 11, 2015

Amphiphilic siloxane-containing vinylic monomers and uses thereof

Inventor: Frank Chang (Cumming, GA)
Assignee: Novartis AG
G02B1/043B29D11/00038C07F7/089C07F7/0849C08F30/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,103,965
App. No.
14/105,275
Granted
Aug 11, 2015
Kind
B2
Abstract

The invention provides an amphiphilic siloxane-containing vinylic monomer which comprises one sole ethylenically unsaturated group and a siloxane-containing group covalently linked to the ethylenically-unsaturated group through a hydrophilic linker. The present invention is also related to a polymer, an actinically-crosslinkable silicone-containing prepolymer, a silicone hydrogel polymeric material, or a silicone hydrogel contact lens, which comprises monomeric units derived from an amphiphilic siloxane-containing vinylic monomer of the invention. In addition, the invention provides a method for making silicone hydrogel contact lenses using a water-based lens-forming formulation comprising an amphiphilic siloxane-containing vinylic monomer of the invention and/or an actinically-crosslinkable silicone-containing prepolymer of the invention.

Claims (35)

1. An amphiphilic siloxane-containing vinylic monomer, comprising: one sole ethylenically unsaturated group (Q), one sole bulky siloxane-containing group BSi, and one hydrophilic linkage (hL) between Q and BSi, wherein the amphiphilic siloxane-containing vinylic monomer is represented by formula (I)

Q-X 1 - h L-X 2 —BSi  (I)

In which:

Q is an ethylenically unsaturated group of formula (II)

in which

R 12 is hydrogen or C 1 -C 4 alkyl,

Z 1 is a linear or branched C 1 -C 12 alkylene radical, —O—, or —NH—,

Z 2 is a direct bond or a linear or branched C 1 -C 12 alkylene radical,

A is —O— or —NH—,

q 1 and q 2 independent of each other are an integer of 0 or 1;

X 1 and X 2 independent of each other are a direct bond or a cross linkage of formula (III)

—X 3 —R′ 1 λ 4 -E-X 5 —R′ 2 —X 6 -  (III)

in which

X 3 , X 4 , X 5 , and X 6 independent of one other are a linkage selected from the group consisting of a direct bond, —O—, —NR′—, —CO—NR′—, —NR′—CO—, —NR′—CO—NH—, —NH—CO—NR′—, —O—CO—NH—, —NH—CO—O—, —S—CO—NH—, —O—CO—, —CO—O—, —S—, and —NH—CO—S— in which R′ is H or C 1 -C 4 alkyl,

E is a linear or branched alkylene, cycloalkane diradical or arene diradical with up to 40 carbon atoms,

R′ 1 and R′ 2 independent of each other is a direct bond, a linear or branched C 1 -C 10 alkylene divalent radical, or a divalent radical of —R′ 3 —X 4 -E-X 5 —R′ 4 — in which E, X 4 and X 5 are as defined above and R′ 3 and R′ 4 independent of each other are a direct bond or a linear or branched C 1 -C 10 alkylene radical;

hL is a hydrophilic oligomeric segment selected from the group consisting of (1) polyoxazoline (—[(N(COR″)C 2 H 4 — in which R″ is H, methyl or ethyl) which is obtained in a ring-opening polymerization of oxazoline, (2) a polypeptide segment composed of at least one amino acid selected from the group consisting of asparagine, glutamine, alanine, glycine, and combinations thereof, and (3) a hydrophilic polymer segment composed of hydrophilic monomeric units derived from at least one hydrophilic vinylic monomer selected from the group consisting of (meth)acrylamide, N,N-dimethyl(meth)acrylamide, dimethylaminoethyl(meth)acrylate, dimethylaminoethyl(meth)acrylamide, N-vinyl-2-pyrrolidone, N-vinyl-N-methyl isopropylamide, N-vinyl-N-methyl acetamide, N-vinyl formamide, N-vinyl acetamide, N-vinyl isopropylamide, N-vinyl-N-methyl acetamide, N-methyl-3-methylene-2-pyrrolidone, 1-ethyl-3-methylene-2-pyrrolidone, 1-methyl-5-methylene-2-pyrrolidone, 1-ethyl-5-methylene-2-pyrrolidone, 5-methyl-3-methylene-2-pyrrolidone, 5-ethyl-3-methylene-2-pyrrolidone, 1-n-propyl-3-methylene-2-pyrrolidone, 1-n-propyl-5-methylene-2-pyrrolidone, 1-isopropyl-3-methylene-2-pyrrolidone, 1-isopropyl-5-methylene-2-pyrrolidone, 1-n-butyl-3-methylene-2-pyrrolidone, 1-tert-butyl-3-methylene-2-pyrrolidone, and mixtures thereof; BSi is a monovalent radical of formula (1A) or (1B)

in which

Y is a C 1 -C 6 alkylene radical or a C 1 -C 6 substituted alkylene radical containing one or more hydroxyl groups,

B 1 and B 2 independent of each other are C 1 -C 6 alkyl, phenyl, or benzyl,

T is a C 1 -C 12 alkyl or an alkoxyalkyl radical having 3 to 8 carbon atoms,

m is an integer of 0 to 3,

p is an integer of 1 to 6,

r is an integer of 2 to 20,

A 1 , A 2 and A 3 independent of each other are C 1 -C 6 alkyl, phenyl, benzyl, or a radical of formula (2)

in which B 3 , B 4 and B 5 independent of each other are C 1 -C 6 alkyl, phenyl, or benzyl, provided that at least two of A 1 , A 2 and A 3 are radicals of formula (2).

2. The amphiphilic siloxane-containing vinylic monomer of claim 1 , wherein Q is

in which R 12 is hydrogen or methyl and Z 2 is a direct bond or a linear or branched C 1 -C 12 alkylene divalent radical.

3. The amphiphilic siloxane-containing vinylic monomer of claim 2 , wherein BSi is a monovalent radical of formula (1A) in which A1, A2 and A3 is a radical of formula (2).

4. The amphiphilic siloxane-containing vinylic monomer of claim 2 , wherein BSi is a monovalent radical of formula (1B) in which B 1 and B 2 independent of each other are C 1 -C 6 alkyl.

5. The amphiphilic siloxane-containing vinylic monomer of claim 2 , wherein hL in formula (I) is an oligomeric polyoxazoline segment.

6. The amphiphilic siloxane-containing vinylic monomer of claim 2 , wherein hL in formula (I) is an oligomeric polypeptide segment composed of at least one amino acid selected from the group consisting of asparagine, glutamine, alanine, glycine, and combinations thereof.

7. The amphiphilic siloxane-containing vinylic monomer of claim 2 , wherein hL in formula (I) is a hydrophilic polymer segment composed of monomeric units derived from at least one hydrophilic vinylic monomer selected from the group consisting of (meth)acrylamide, N,N-dimethyl(meth)acrylamide, dimethylaminoethyl(meth)acrylate, dimethylaminoethyl(meth)acrylamide, N-vinyl-2-pyrrolidone, N-vinyl-N-methyl isopropylamide, N-vinyl-N-methyl acetamide, N-vinyl formamide, N-vinyl acetamide, N-vinyl isopropylamide, N-vinyl-N-methyl acetamide, N-methyl-3-methylene-2-pyrrolidone, 1-ethyl-3-methylene-2-pyrrolidone, 1-methyl-5-methylene-2-pyrrolidone, 1-ethyl-5-methylene-2-pyrrolidone, 5-methyl-3-methylene-2-pyrrolidone, 5-ethyl-3-methylene-2-pyrrolidone, 1-n-propyl-3-methylene-2-pyrrolidone, 1-n-propyl-5-methylene-2-pyrrolidone, 1-isopropyl-3-methylene-2-pyrrolidone, 1-isopropyl-5-methylene-2-pyrrolidone, 1-n-butyl-3-methylene-2-pyrrolidone, 1-tert-butyl-3-methylene-2-pyrrolidone, and mixtures thereof.

8. The amphiphilic siloxane-containing vinylic monomer of claim 7 , wherein hL in formula (I) is a hydrophilic polymer segment composed of monomeric units derived from at least one hydrophilic vinylic monomer selected from the group consisting of (meth)acrylamide, N,N-dimethyl(meth)acrylamide, dimethylaminoethyl(meth)acrylate, dimethylaminoethyl(meth)acrylamide, N-vinyl-2-pyrrolidone, N-vinyl-N-methyl acetamide, N-vinyl acetamide, N-methyl-3-methylene-2-pyrrolidone, 1-methyl-5-methylene-2-pyrrolidone, 5-methyl-3-methylene-2-pyrrolidone, and mixtures thereof.

9. The amphiphilic siloxane-containing vinylic monomer of claim 2 , wherein the amphiphilic siloxane-containing vinylic monomer has a water solubility or dispersibility of at least about 5% by weight in water.

Assignments (2)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2014
From: CHANG, FRANK
To: NOVARTIS AG
Reel/Frame 032839/0669 →
Continuity (2)
Provisional Application 61737206 · Dec 14, 2012
Related Publication 20140171542A1 · Jun 19, 2014